Delivery Order SPE2DB22D1106-SPE2DB25FFJF6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.28 to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL in vials. This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a competitively awarded, non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a $13,917.06 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylergonovine 0.2 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of September 25, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL in a one-milliliter volume on July 9, 2025, with a ceiling value of $4,786.56. This firm fixed-price delivery order, which completes on July 10, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, an oxytocic medication used primarily in obstetric care. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJF6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care, valued at $5,983.20 with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, was executed on September 15, 2025, with an ultimate completion date of September 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime contractor under this comprehensive pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill diverse medical procurement requirements through competitive procurement processes and firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/15/25 |